With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic ...

Novo Nordisk said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a ...

There could be 2,000 new HIV infections a day across the world and a ten-fold increase in related deaths if funding frozen by ...

SAP has overtaken Danish drugmaker Novo Nordisk to become Europe’s most valuable listed company, marking a major milestone ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

German business-software group SAP claimed the top spot as Europe’s largest company by market value, dethroning Danish ...

Novo Nordisk slashes costs and expands access to its blockbuster weight-loss drug, shaking up a potential $100B market overnight.

First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...

Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

Novo has been trying to strengthen its foothold in the potential $150 billion obesity market through the development of ...